Theravance Biopharma, Inc. (TBPH) stock prices updated...
 

Theravance Biopharma, Inc. stock price

Theravance Biopharma, Inc. latest news:


  • 11/16/2017 15:30:44

    BRIEF-Theravance Biopharma highlights marketing authorization in Europe for Trelegy Ellipta as once-daily single ...

    Theravance Biopharma Inc(TBPH). * Theravance Biopharma(TBPH) highlights marketing authorization in Europe for Trelegy Ellipta as once-daily single inhaler triple therapy for the treatment of COPD Source text for Eikon: Further company coverage:

  • 11/01/2017 07:05:17

    BRIEF-Theravance Biopharma and Mylan reports positive Phase 3 data for Revefenacin

    Mylan Nv(MYL). * Theravance Biopharma(TBPH) and mylan report additional positive phase 3 data for Revefenacin in multiple presentations at 2017 Chest Annual Meeting.

  • 10/09/2017 06:53:29

    BRIEF-Theravance Biopharma reports positive new data from multiple studies of VIBATIV at IDWeek 2017

    * Theravance Biopharma reports positive new data from multiple studies of VIBATIV (telavancin) at IDWeek 2017

  • More trends:

    Theravance, Inc.THRX | TheStreet, Inc.TST | THL Credit, Inc.TCRD | Thoratec CorporationTHOR | Threshold Pharmaceuticals, Inc.THLD | THT Heat Transfer Technology, Inc.THTI | TICC Capital Corp.TICC | TigerLogic CorporationTIGR | Tile Shop Hldgs, Inc.TTS | Till Capital Ltd.TIL |